Before Monday’s opening bell, a number of big name dividend stocks were the subject of analyst moves. Below, we highlight the most important analyst commentary for investors.
UnitedHealth Group Boosted to “Buy”
UnitedHealth Group (UNH ) has been upgraded from “Hold” to “Buy” at Jefferies as the company may increase market share in fast growing areas. UNH has a dividend yield of 1.26%.
BMO Capital Upgrades AbbVie
AbbVie (ABBV ) has been upgraded from “Market Perform” to “Outperform” at BMO Capital on a valuation call. ABBV has a dividend yield of 3.29%.
Citi Raises Estimates on Walgreens Boots Alliance
Citigoup has raised its price target on Walgreens Boots Alliance (WBA ) to $107. This new price target suggests a 16% increase from the stock’s current price. The firm boosted estimates on WBA due to higher expected growth. WBA has a dividend yield of 1.47%.
St. Jude Medical Upgraded to “Neutral”
St. Jude Medical (STJ) has been upgraded from “Underperform” to “Neutral” at Credit Suisse as its business is expected gain momentum in the next year. STJ has a dividend yield of 1.70%.
Freeport-McMoRan Upgraded at Citi
Freeport-McMoRan (FCX ) has been boosted to “Buy” at Citigroup as analysts expect the copper market to improve by 2016. FCX has a dividend yield of 1.09%.
